MYDA ADVISORS LLC CRISPR Therapeutics AG Transaction History

MYDA ADVISORS LLC portfolio value:

$327,000
portfolio value

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Decrease -50.00% -5K shares -281K $65.35 5K
Q2 2022 call Increase 0.00% 10K shares 608K $60.77 10K
Q1 2020 share Decrease -100.00% -14K shares -853K $42.41 0
Q4 2019 share Increase 0.00% 14K shares 853K $60.91 14K